Kahn Clare 4
4 · Solid Biosciences Inc. · Filed Jun 13, 2024
Insider Transaction Report
Form 4
Kahn Clare
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2024-06-11+34,400→ 34,400 totalExercise: $7.51Exp: 2034-06-11→ Common Stock (34,400 underlying)
Footnotes (1)
- [F1]This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.